A new phase 1 trial demonstrates the safety and effectiveness of personalized neoantigen DNA vaccines, showing promising immune responses and improved recurrence-free survival in high-risk triple-negative breast cancer patients.

After surgery, the team analyzed and compared the tumor tissue with the healthy tissue of the same patient to find unique genetic mutations

An experimental vaccine teaching patients’ immune systems to identify and attack cancer cells could help women diagnosed with triple-negative breast cancer.

We acknowledge the limitations of this type of analysis, but we are continuing to pursue this vaccine strategy and have ongoing randomized controlled trials that do make a dire

An experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breast cancer, new research suggests.

Breast cancer patients have been given fresh hope after a new vaccine showed "promise" in treating an aggressive form of the disease. The results came in a clinical trial involving American patients with triple-negative breast cancer who received an experimental jab designed to prevent the recurrence of tumors.

Breast cancer patients have been given fresh hope after a new vaccine showed “promise” in treating an aggressive form of the disease. The results came in a clinical trial involving American patients with triple-negative breast cancer who received an experimental jab designed to prevent the recurrence of tumours.